Chemotherapy Combined With Bevacizumab Neoadjuvant Therapy for HER2-negative Breast Cancer
Clinical trial NCT05525767 · RECRUITING
Trial details
- NCT number
- NCT05525767
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-31
- Primary completion
- 2026-10-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.